keep em coming i say.
key line for me was our direct sales presence building momentum.
this is all good fodder for the fuji negotiations.
agree, labcon still a significant wait. biggest issue for me is the lack of working capital and its limitatioms in terms of playing a long game with fuji.
dyor
Ann: Bluechiip adds third top-20 global pharma to customer list, page-7
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.616M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BCT (ASX) Chart |
Day chart unavailable